Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total
Balance at beginning of period at Dec. 31, 2020	$ 57	$ 116,732	$ (9,817)	$ (7,855)	$ 99,117
Balance (in shares) at Dec. 31, 2020	5,663,040
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense		214			214
Exercise of stock options		6			6
Exercise of stock options (in shares)	233
Sale of common stock	$ 19	108,657			108,676
Sale of common stock (in shares)	1,927,049
Special dividend	$ 1	7,845	(11,250)		(3,404)
Special dividend (in shares)	125,212
Net income (loss)			(768)		(768)
Total other comprehensive income, net of tax				3,479	3,479
Balance at end of period at Mar. 31, 2021	$ 77	233,454	(21,835)	(4,376)	207,320
Balance (in shares) at Mar. 31, 2021	7,715,534
Balance at beginning of period at Dec. 31, 2021	$ 102	399,754	(10,869)	(2,910)	386,077
Balance (in shares) at Dec. 31, 2021	10,183,730
Increase (Decrease) in Stockholders' Equity
Equity awards issued (in shares)	2,698
Stock-based compensation expense		273			273
Shares acquired to satisfy employee tax withholding requirements on stock awards		(23)			(23)
Shares acquired to satisfy employee tax withholding requirements on stock awards (in shares)	(285)
Common stock dividends			(1,630)		(1,630)
Net income (loss)			269		269
Total other comprehensive income, net of tax				4,662	4,662
Balance at end of period at Mar. 31, 2022	$ 102	$ 400,004	$ (12,230)	$ 1,752	$ 389,628
Balance (in shares) at Mar. 31, 2022	10,186,143